Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients
about
Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients
description
scientific article published on 07 December 2018
@en
name
Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients
@en
type
label
Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients
@en
prefLabel
Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients
@en
P2093
P50
P356
P1476
Ribociclib in HR+/HER2- Advanced or Metastatic Breast Cancer Patients
@en
P2093
Goran Flajc
Kaitlin Rascon
P304
P356
10.1177/1060028018817904
P577
2018-12-07T00:00:00Z